Thanks, ghmm. CEO bought $7 million last month that
gave me the confidence to buy. Like you said there
are more good news to come. I still feel there are
something alse good to come for CEO to buy in open
market first time, and UTHR should split the stock
to increase the institution base, it will not
swing down 40% and up 40% so often. Fundamentally,
UTHR should be worth $120 now. With forward PE 28,
market cap 6.5 X sales, it is a very reasonable
valution for a drug company with growth 30+% for
years to come.
Market Data 
Markets 
AI
